| Primary |
| Hiv Infection |
60.0% |
| Antiretroviral Therapy |
8.4% |
| Drug Use For Unknown Indication |
8.4% |
| Antibiotic Therapy |
3.9% |
| Hepatitis C |
3.3% |
| Product Used For Unknown Indication |
3.1% |
| Tuberculosis |
2.3% |
| Prophylaxis |
1.6% |
| Systemic Antiviral Treatment |
1.6% |
| Toxoplasmosis |
1.2% |
| Hypertension |
0.8% |
| Opportunistic Infection Prophylaxis |
0.8% |
| Anaemia |
0.6% |
| Antifungal Prophylaxis |
0.6% |
| Antiviral Prophylaxis |
0.6% |
| Neuropathy Peripheral |
0.6% |
| Pain |
0.6% |
| Post-traumatic Stress Disorder |
0.6% |
| Asthma |
0.4% |
| Infection Prophylaxis |
0.4% |
|
| Death |
17.3% |
| Pyrexia |
10.0% |
| Renal Failure Acute |
9.1% |
| Bronchitis |
5.5% |
| Urinary Tract Infection |
5.5% |
| Renal Failure |
4.5% |
| Virologic Failure |
4.5% |
| Vomiting |
4.5% |
| Abortion Spontaneous |
3.6% |
| Dehydration |
3.6% |
| Rectal Haemorrhage |
3.6% |
| Rhabdomyolysis |
3.6% |
| Syncope |
3.6% |
| Treatment Failure |
3.6% |
| Weight Decreased |
3.6% |
| Anaemia |
2.7% |
| Congenital Musculoskeletal Anomaly |
2.7% |
| Diarrhoea |
2.7% |
| Hiv Infection |
2.7% |
| Lymphadenitis |
2.7% |
|
| Secondary |
| Hiv Infection |
63.1% |
| Drug Use For Unknown Indication |
11.1% |
| Drug Exposure During Pregnancy |
4.4% |
| Prophylaxis |
4.1% |
| Human Immunodeficiency Virus Transmission |
2.9% |
| Product Used For Unknown Indication |
2.7% |
| Acquired Immunodeficiency Syndrome |
2.3% |
| Antiretroviral Therapy |
2.2% |
| End Stage Aids |
1.4% |
| Systemic Antiviral Treatment |
1.1% |
| Antifungal Prophylaxis |
0.8% |
| Maternal Exposure During Pregnancy |
0.6% |
| Contraception |
0.5% |
| Disseminated Tuberculosis |
0.5% |
| Prophylaxis Against Hiv Infection |
0.5% |
| Thrombosis Prophylaxis |
0.5% |
| Antibiotic Therapy |
0.4% |
| Hiv Test Positive |
0.4% |
| Pain |
0.4% |
| Retroviral Infection |
0.4% |
|
| Weight Decreased |
13.3% |
| Progressive External Ophthalmoplegia |
12.8% |
| Pyrexia |
6.7% |
| Renal Failure Acute |
6.7% |
| Viral Mutation Identified |
6.7% |
| Rhabdomyolysis |
6.2% |
| Upper Gastrointestinal Haemorrhage |
5.6% |
| Subdural Haematoma |
5.1% |
| Premature Baby |
4.6% |
| Renal Failure |
4.6% |
| Stress |
3.6% |
| Drug Exposure During Pregnancy |
3.1% |
| Myalgia |
3.1% |
| Sepsis |
3.1% |
| Virologic Failure |
3.1% |
| Vomiting |
3.1% |
| Wrong Technique In Drug Usage Process |
2.6% |
| Immune Reconstitution Syndrome |
2.1% |
| Pruritus |
2.1% |
| Renal Aplasia |
2.1% |
|
| Concomitant |
| Hiv Infection |
64.0% |
| Drug Use For Unknown Indication |
13.5% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Product Used For Unknown Indication |
2.3% |
| Depression |
2.0% |
| Hypertension |
1.8% |
| Antiretroviral Therapy |
1.7% |
| Prophylaxis |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Antibiotic Prophylaxis |
1.2% |
| Infection Prophylaxis |
1.0% |
| Medical Diet |
1.0% |
| Oral Candidiasis |
0.9% |
| Hypercholesterolaemia |
0.8% |
| Antiviral Prophylaxis |
0.7% |
| Chest Pain |
0.7% |
| Diarrhoea |
0.7% |
| Cerebral Toxoplasmosis |
0.6% |
| Hodgkin's Disease |
0.6% |
| Human Immunodeficiency Virus Transmission |
0.6% |
|
| Vomiting |
10.4% |
| Upper Gastrointestinal Haemorrhage |
9.2% |
| Thrombocytopenia |
8.0% |
| Pyrexia |
7.4% |
| Liver Function Test Abnormal |
6.7% |
| Death |
6.1% |
| Meningitis Cryptococcal |
5.5% |
| Neuropathic Ulcer |
4.9% |
| Blood Creatinine Increased |
4.3% |
| Hepatitis Cholestatic |
4.3% |
| Overdose |
4.3% |
| Renal Failure Acute |
4.3% |
| Pancreatitis |
3.7% |
| Varices Oesophageal |
3.7% |
| Drug Interaction |
3.1% |
| Rash Maculo-papular |
3.1% |
| Thrombotic Thrombocytopenic Purpura |
3.1% |
| Visual Disturbance |
3.1% |
| Acute Coronary Syndrome |
2.5% |
| Ascites |
2.5% |
|
| Interacting |
| Hiv Infection |
73.9% |
| Antiretroviral Therapy |
21.7% |
| Hypothyroidism |
4.3% |
|
| Weight Decreased |
85.7% |
| Injection Site Nodule |
14.3% |
|
